Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness and Safety of Local Endoscopically-assisted Administration of Autologous Adipose-derived Regenerative Cells for Reduction of Risk of Postoperative Bladder Neck Contracture in Male Patients

NCT02869061 is registered in ClinicalTrials.gov with Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation as lead sponsor.

NCT NCT02869061
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02869061 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness and Safety of Local Endoscopically-assisted Administration of Autologous Adipose-derived Regenerative Cells for Reduction of Risk of Postoperative Bladder Neck Contracture in Male Patients
Lead sponsor
Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation
Phase
Phase 1/2
Overall status
Unknown status
Start date
January 31, 2016
Completion date
December 31, 2018
Enrollment
12 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

benign prostatic hyperplasia, bladder neck obstruction, bladder outlet obstruction, urinary bladder neck obstruction